Sutent scores against Steve Jobs-type cancer

Pfizer's Sutent delayed the worsening of the type of pancreatic cancer that afflicted Apple Chief Executive Steve Jobs by more than five months longer than a placebo, according to data from a clinical trial. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.